265 related articles for article (PubMed ID: 32468528)
1. Artificial Neural Networks in Computer-Aided Drug Design: An Overview of Recent Advances.
Cheirdaris DG
Adv Exp Med Biol; 2020; 1194():115-125. PubMed ID: 32468528
[TBL] [Abstract][Full Text] [Related]
2. Improving quantitative structure-activity relationship models using Artificial Neural Networks trained with dropout.
Mendenhall J; Meiler J
J Comput Aided Mol Des; 2016 Feb; 30(2):177-89. PubMed ID: 26830599
[TBL] [Abstract][Full Text] [Related]
3. Have artificial neural networks met expectations in drug discovery as implemented in QSAR framework?
Dobchev D; Karelson M
Expert Opin Drug Discov; 2016 Jul; 11(7):627-39. PubMed ID: 27149299
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence approaches for rational drug design and discovery.
Duch W; Swaminathan K; Meller J
Curr Pharm Des; 2007; 13(14):1497-508. PubMed ID: 17504169
[TBL] [Abstract][Full Text] [Related]
5. Deep Learning in Structure-Based Drug Design.
Anighoro A
Methods Mol Biol; 2022; 2390():261-271. PubMed ID: 34731473
[TBL] [Abstract][Full Text] [Related]
6. Digital Pharmaceutical Sciences.
Damiati SA
AAPS PharmSciTech; 2020 Jul; 21(6):206. PubMed ID: 32715351
[TBL] [Abstract][Full Text] [Related]
7. Neural networks in building QSAR models.
Baskin II; Palyulin VA; Zefirov NS
Methods Mol Biol; 2008; 458():137-58. PubMed ID: 19065809
[TBL] [Abstract][Full Text] [Related]
8. Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.
Butkiewicz M; Lowe EW; Mueller R; Mendenhall JL; Teixeira PL; Weaver CD; Meiler J
Molecules; 2013 Jan; 18(1):735-56. PubMed ID: 23299552
[TBL] [Abstract][Full Text] [Related]
9. An Inverse QSAR Method Based on Linear Regression and Integer Programming.
Zhu J; Azam NA; Haraguchi K; Zhao L; Nagamochi H; Akutsu T
Front Biosci (Landmark Ed); 2022 Jun; 27(6):188. PubMed ID: 35748264
[TBL] [Abstract][Full Text] [Related]
10. Deep Neural Networks for QSAR.
Xu Y
Methods Mol Biol; 2022; 2390():233-260. PubMed ID: 34731472
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Structure Activity/Toxicity Relationship through Neural Networks for Drug Discovery or Regulatory Use.
Novič M
Curr Top Med Chem; 2023; 23(29):2792-2804. PubMed ID: 37867278
[TBL] [Abstract][Full Text] [Related]
12. Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.
Mouchlis VD; Afantitis A; Serra A; Fratello M; Papadiamantis AG; Aidinis V; Lynch I; Greco D; Melagraki G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562347
[TBL] [Abstract][Full Text] [Related]
13. Machine learning models for classification tasks related to drug safety.
Rácz A; Bajusz D; Miranda-Quintana RA; Héberger K
Mol Divers; 2021 Aug; 25(3):1409-1424. PubMed ID: 34110577
[TBL] [Abstract][Full Text] [Related]
14. What are artificial neural networks and what they can do?
Dohnal V; Kuca K; Jun D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):221-4. PubMed ID: 16601760
[TBL] [Abstract][Full Text] [Related]
15. [Artificial intelligence and machine learning in oncologic imaging].
Kleesiek J; Murray JM; Strack C; Prinz S; Kaissis G; Braren R
Pathologe; 2020 Nov; 41(6):649-658. PubMed ID: 33052431
[TBL] [Abstract][Full Text] [Related]
16. Merging Counter-Propagation and Back-Propagation Algorithms: Overcoming the Limitations of Counter-Propagation Neural Network Models.
Drgan V; Venko K; Sluga J; Novič M
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673742
[TBL] [Abstract][Full Text] [Related]
17. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research.
Agatonovic-Kustrin S; Beresford R
J Pharm Biomed Anal; 2000 Jun; 22(5):717-27. PubMed ID: 10815714
[TBL] [Abstract][Full Text] [Related]
18. Computer-Aided Drug Design: An Update.
Yu W; Weber DJ; MacKerell AD
Methods Mol Biol; 2023; 2601():123-152. PubMed ID: 36445582
[TBL] [Abstract][Full Text] [Related]
19. Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines (GA-SVM).
Fernandez M; Caballero J; Fernandez L; Sarai A
Mol Divers; 2011 Feb; 15(1):269-89. PubMed ID: 20306130
[TBL] [Abstract][Full Text] [Related]
20. Modeling Physico-Chemical ADMET Endpoints with Multitask Graph Convolutional Networks.
Montanari F; Kuhnke L; Ter Laak A; Clevert DA
Molecules; 2019 Dec; 25(1):. PubMed ID: 31877719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
